IL6 and rheumatoid arthritis: Li et al. [37] indicated the −590 site and −174 site polymorphisms in the promoter of IL-4 and IL-6, respectively, may be associated with increased risk of RA and could be used as genetic markers for assessing the susceptibility and severity of RA.